Development of a Web-based, self-reporting symptom diary for Crohn's Disease, and its correlation with the Crohn's Disease Activity Index☆
Sign Up to like & getrecommendations! Published in 2017 at "Journal of Crohn's and Colitis"
DOI: 10.1016/j.crohns.2014.09.003
Abstract: Background and Aims Crohn's Disease Activity Index (CDAI) is complex, time-consuming, and impractical. The aim of this study was to investigate whether a newly developed, simple, web-based self-reporting Crohn's Disease symptom diary (CDSD) was as… read more here.
Keywords: cdai; index; disease; correlation ... See more keywords
Patient outcomes improve when a molecular signature test guides treatment decision-making in rheumatoid arthritis
Sign Up to like & getrecommendations! Published in 2022 at "Expert Review of Molecular Diagnostics"
DOI: 10.1080/14737159.2022.2140586
Abstract: ABSTRACT Background The molecular signature response classifier (MSRC) predicts tumor necrosis factor-ɑ inhibitor (TNFi) non-response in rheumatoid arthritis. This study evaluates decision-making, validity, and utility of MSRC testing. Methods This comparative cohort study compared an… read more here.
Keywords: molecular signature; signature; cdai; rheumatoid arthritis ... See more keywords
AB0014 Genetic influence of different measure for tumour necrosis factor inhibitors response in rheumatoid arthritis
Sign Up to like & getrecommendations! Published in 2018 at "Annals of the Rheumatic Diseases"
DOI: 10.1136/annrheumdis-2018-eular.5286
Abstract: Background The genetic studies of tumour necrosis factor inhibitors (TNFi) response in patients with rheumatoid arthritis (RA) have largely relied on the changes in complex disease scores as a measure of treatment response. It is… read more here.
Keywords: response; disease; disease activity; heritability ... See more keywords
AB0277 EFFECT OF DISEASE DURATION AND OTHER PATIENT BASELINE CHARACTERISTICS ON OUTCOMES IN TOCILIZUMAB-TREATED RHEUMATOID ARTHRITIS PATIENTS: A POOLED ANALYSIS
Sign Up to like & getrecommendations! Published in 2019 at "Annals of the Rheumatic Diseases"
DOI: 10.1136/annrheumdis-2019-eular.1144
Abstract: Background Tocilizumab (TCZ) efficacy and safety in rheumatoid arthritis (RA) have been well established by numerous phase 3 and 4 studies and observational studies. Objectives To explore the extent to which disease duration, inflammation, disease… read more here.
Keywords: cdai; duration; baseline; roche ... See more keywords
AB0233 ATTAINING CDAI REMISSION IS THE FIRST GATEWAY TO ATTAIN BOOLEAN REMISSION
Sign Up to like & getrecommendations! Published in 2020 at "Annals of the Rheumatic Diseases"
DOI: 10.1136/annrheumdis-2020-eular.1550
Abstract: Background: Boolean remission is most stringent but most comparable remission status for the patient with rheumatoid arthritis (RA). Clinical remission evaluated with clinical disease activity index (CDAI) is also one of the most popular index… read more here.
Keywords: boolean remission; score; cdai; cdai remission ... See more keywords
AB0211 DIFFERENTIAL INFLUENCE OF CDAI COMPONENTS BASED ON DISEASE STATE IN RHEUMATOID ARTHRITIS PATIENTS: REAL-WORLD RESULTS FROM THE ONTARIO BEST PRACTICES RESEARCH INITIATIVE (OBRI)
Sign Up to like & getrecommendations! Published in 2020 at "Annals of the Rheumatic Diseases"
DOI: 10.1136/annrheumdis-2020-eular.3913
Abstract: Treat-to-target recommendations for rheumatoid arthritis (RA) dictate that remission or low disease activity should be aimed. Although numerous composite indices are available, the clinical disease activity index (CDAI) is commonly used in routine clinical care… read more here.
Keywords: cdai; inc; research; disease ... See more keywords
OP0101 RHEUMATOID ARTHRITIS DISEASE ACTIVITY OVER TIME AND SUBSEQUENT CARDIOVASCULAR RISKS.
Sign Up to like & getrecommendations! Published in 2021 at "Annals of the Rheumatic Diseases"
DOI: 10.1136/annrheumdis-2021-eular.28
Abstract: Rheumatoid arthritis (RA) patients have an increased risk of cardiovascular (CV) events not fully explained by traditional CV risk factors. The relationship between fluctuating inflammation due to RA disease activity and CV events is of… read more here.
Keywords: time; disease activity; cdai; disease ... See more keywords
POS0628 FAILURE TO SUSTAIN TREATMENT TARGET AFTER TAPERING TOCILIZUMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS: 4-YEAR LONGITUDINAL DATA FROM A NATIONWIDE COHORT
Sign Up to like & getrecommendations! Published in 2021 at "Annals of the Rheumatic Diseases"
DOI: 10.1136/annrheumdis-2021-eular.2818
Abstract: Tapering biologic therapy after achieving clinical remission or low disease activity (LDA) has become a viable option in daily clinical practice of treating patients with rheumatoid arthritis (RA). There are yet few studies investigating its… read more here.
Keywords: disease activity; treatment; cdai; year ... See more keywords
Association of the Composite dietary antioxidant index with all-cause and cardiovascular mortality: A prospective cohort study
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Cardiovascular Medicine"
DOI: 10.3389/fcvm.2022.993930
Abstract: Background According to epidemiological and experimental data, high individual dietary antioxidant intake is correlated with reduced cancer risk. The correlations between combined dietary antioxidants and the risk of all-cause and cardiovascular mortality remain unclear. Consequently,… read more here.
Keywords: cdai; mortality; cause cardiovascular; dietary antioxidant ... See more keywords